First Trust Advisors LP Cardiovascular Systems Inc Transaction History

First Trust Advisors LP

$118 Billion
Q2 2025

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$16.14 - $22.6 $246,974 - $345,825	-15,302 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$18.64 - $36.77 $60,580 - $119,502	3,250 Added 26.97%	15,302 $287,000
Q3 2021 Nov 15, 2021	BUY	$32.83 - $43.0 $395,667 - $518,236	12,052 New	12,052 $396,000
Q2 2021 Aug 16, 2021	SELL	$34.41 - $44.03 $427,062 - $546,456	-12,411 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$37.29 - $47.19 $69,844 - $88,386	-1,873 Reduced 13.11%	12,411 $476,000
Q4 2020 Feb 02, 2021	BUY	$34.3 - $44.09 $489,941 - $629,781	14,284 New	14,284 $625,000
Q3 2020 Nov 05, 2020	SELL	$27.86 - $39.35 $842,709 - $1.19 Million	-30,248 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$30.3 - $42.55 $157,741 - $221,515	-5,206 Reduced 14.68%	30,248 $954,000
Q1 2020 May 06, 2020	SELL	$30.0 - $54.18 $611,460 - $1.1 Million	-20,382 Reduced 36.5%	35,454 $1.25 Million
Q4 2019 Feb 03, 2020	SELL	$42.29 - $52.2 $593,413 - $732,470	-14,032 Reduced 20.08%	55,836 $2.71 Million
Q3 2019 Nov 04, 2019	SELL	$42.06 - $51.64 $106,117 - $130,287	-2,523 Reduced 3.49%	69,868 $3.32 Million
Q2 2019 Jul 30, 2019	BUY	$33.93 - $43.66 $331,088 - $426,034	9,758 Added 15.58%	72,391 $3.11 Million
Q1 2019 May 09, 2019	SELL	$26.74 - $41.32 $281,117 - $434,397	-10,513 Reduced 14.37%	62,633 $2.42 Million
Q4 2018 Feb 07, 2019	BUY	$25.26 - $38.43 $1.85 Million - $2.81 Million	73,146 New	73,146 $2.08 Million
Q4 2017 Feb 08, 2018	SELL	$23.37 - $29.26 $1.41 Million - $1.76 Million	-60,314 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$27.25 - $31.55 $1.64 Million - $1.9 Million	60,314	60,314 $1.7 Million

Others Institutions Holding CSII

# of Institutions

Shares Held

35.5K

Call Options Held

Put Options Held

View Full List

About Cardiovascular Systems Inc

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

More about CSII

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account